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Meckel′s cartilage is a transient supporting tissue of the embryonic mandible in mammals, and
disappears by taking different ultimate cell fate along the distal–proximal axis, with the majority
(middle portion) undergoing degeneration and chondroclastic resorption. While a number of factors
have been implicated in the degeneration and resorption processes, signaling pathways that trigger this
degradation are currently unknown. BMP signaling has been implicated in almost every step of
chondrogenesis. In this study, we used Noggin mutant mice as a model for gain-of-BMP signaling
function to investigate the function of BMP signaling in Meckel′s cartilage development, with a focus on
the middle portion. We showed that Bmp2 and Bmp7 are expressed in early developing Meckels′
cartilage, but their expression disappears thereafter. In contrast, Noggin is expressed constantly in Meckel′s
cartilage throughout the entire gestation period. In the absence of Noggin, Meckel′s cartilage is signiﬁcantly
thickened attributing to dramatically elevated cell proliferation rate associated with enhanced phosphory-
lated Smad1/5/8 expression. Interestingly, instead of taking a degeneration fate, the middle portion of
Meckel′s cartilage in Noggin mutants undergoes chondrogenic differentiation and endochondral ossiﬁca-
tion contributing to the forming mandible. Chondrocyte-speciﬁc expression of a constitutively active form
of BMPRIa but not BMPRIb leads to enlargement of Meckel′s cartilage, phenocopying the consequence of
Noggin deﬁciency. Our results demonstrate that elevated BMP signaling prevents degeneration and leads to
endochondral ossiﬁcation of Meckel′s cartilage, and support the idea that withdrawal of BMP signaling is
required for normal Meckel′s cartilage development and ultimate cell fate.
& 2013 Elsevier Inc. All rights reserved.Introduction
In mammals, Meckel′s cartilage acts as a transient support tissue in
mandibular arch during early embryogenesis and disappears at late
gestation or neonatal stage of development (Dixon, 1997). In mice, the
development of Meckel′s cartilage, which derives from cranial neural
crest (CNC) cells, begins at the ﬁrst molar bud region at embryonic day
11 (E11), and continues with extension at both the anterior and
posterior ends with addition of CNC cells at the chondrogenic front,
forming a pair of rod-like hyaline cartilage (Ito et al., 2002). Previous
studies have established different ultimate fates of Meckel′s cartilage
in rodents (Bhaskar et al., 1953; Bernick and Patek, 1969; Savostin-
Asling and Asling, 1973; Harada and Ishizeki, 1998; Ishizeki et al.,
2001). The distal region of Meckel′s cartilage undergoes endochondral
ossiﬁcation contributing to the symphysis of the mandible, whereasll rights reserved.the most proximal portion (caudal end) gives rise to malleus and incus
through endochondral ossiﬁcation as well. However, in the middle
portion, which counts for the majority of Meckel′s cartilage, the
chondrocytes become hypertrophic, but never further differentiate
and undergo degeneration subsequently, except that the posterior part
of this portion is replaced by the sphenomandibular ligament (Harada
and Ishizeki, 1998).
Similar to the development of other fetal cartilaginous skeleton,
chondrogenesis of Meckel′s cartilage progresses via mesenchymal
cell condensation, proliferation, and differentiation of chondrocytes.
Despite its CNC-origin, the initial chondrogenesis of Meckel′s carti-
lage shares many similar mechanisms with those mesoderm-derived
cartilaginous elements. For example, Sox9 is required for the deter-
mination of chondrogenic lineage in axial and appendicular skeletal
elements as well as CNC-derived cartilages and endochondral bones
(Bi et al., 1999; Mori-Akiyama et al., 2003). In addition, a number of
signaling molecules, including bone morphogenetic protein (BMP),
connective tissue growth factor (CTGF), ﬁbroblast growth factor
(FGF), transforming growth factor β (TGFβ), and Wnt that are known
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implicated in Meckel′s cartilage development (Chai et al., 1994;
Nonaka et al., 1999; Ito et al., 2002; Shimo et al., 2004; Terao et al.,
2011; Zhang et al., 2011). However, unlike the fate of those
mesoderm-derived cartilaginous elements and other CNC-derived
cartilages such as cranial base, the majority of Meckel′s cartilage does
not develop further and becomes degenerated. While previous
studies have revealed potential contributions of several factors and
cellular processes to the disappearance/resorption (Trichilis and
Wroblewski, 1997; Harada and Ishizeki, 1998; Sakakura et al., 2005,
2007a, 2007b; Tsuzurahara et al., 2011; Yang et al., 2012), signaling
pathways that prevent further differentiation and trigger degenera-
tion of Meckel′s cartilage remain elusive.
BMP signaling acts via binding to heterotetrameric complexes of
type I and II receptors, leading to activation of Smad-dependent
canonical pathway and Smad-independent noncanonical MAPK path-
ways that regulate targeted gene expression (Massagué, 2012). BMP
signaling plays important roles in multiple steps of chondrogenesis
and endochondral bone formation. In the earliest stage of chondro-
genesis, BMP signaling promotes mesenchymal cells to differentiate
into chondrocytes and stimulates chondrocyte proliferation by indu-
cing Sox9 expression (Denker et al., 1999; Zehentner et al., 1999; Yoon
et al., 2005). BMP signaling also controls chondrocyte differentiation
by promoting chondrocyte hypertrophy and is required for endochon-
dral bone formation (Minina et al., 2001; Valcourt et al., 2002;
Kobayashi et al., 2005; Retting et al., 2009).
Noggin is a potent BMP antagonist, binding preferentially to BMP2,
BMP4, and BMP7 to prevent their signaling (Zimmerman et al., 1996;
Groppe et al., 2002; Chen et al., 2004). Noggin deﬁciency in mice, a
model of gain-of-BMP function, leads to overgrowth of skeletal
elements including the mandible (Brunet et al., 1998; Stottmann
et al., 2001). However, whether or not loss of Noggin alters the
development of Meckel′s cartilage has not been reported. In our and
other′s previous studies on the effects of overdosed BMP activity on
the development of palate, tooth, and temporomandibular joint using
Nogginmutant mice as amodel, the formation of signiﬁcantly enlarged
Meckel′s cartilagewas observed (He et al., 2010; Lana-Elola et al., 2011;
Wang et al., 2011; Hu et al., 2012). In the present study, we followed
up our previous observation by detailed analysis of the phenotype in
Nogginmutants with focus on themiddle portion of Meckel′s cartilage.
We show here that Noggin is expressed constantly in Meckel′s
cartilage throughout the entire embryonic stage, whereas Bmp2 and
Bmp7 but not Bmp4 are expressed in developing Meckel′s cartilage
only at the early stage. In the absence of Noggin, the expression of
phosphorylated Smad1/5/8 is signiﬁcantly elevated associated with
enhanced cell proliferation rate in Meckel′s cartilage, leading to
formation of enlarged Meckel′s cartilage. Instead becoming arrest of
further differentiation and subsequent degeneration, Meckel′s carti-
lage in Noggin mutants undergoes endochondral differentiation, uni-
fying with the developing mandibular bone to form a larger mandible.
Forced expression of a constitutively active form of BMPRIa in
chondrocyte lineage also produces enlarged Meckel′s cartilage,
mimicking the consequence of Noggin deﬁciency. We conclude that
withdrawal of BMP signaling represents an essential step for arrest of
chondrogenic differentiation and subsequent degeneration of Meckel′s
cartilage during development.Materials and methods
Animals
The generation of Noggin mutant (Nog+/), Col2a1-CreERT2,
Rosa26 reporter, pMes-caBmprIa, and pMes-caBmprIb mice have
been described previously (Soriano, 1999; McMahon et al., 1998;
Chen et al., 2007; He et al., 2010; Yu et al., 2010). Nog / embryoswere harvested from timed pregnant Nog+/ females mated with
Nog+/ males. To achieve chondrocyte-speciﬁc expression of consti-
tutively active form of BMPRIa or BMPRIb in developing embryos,
Col2-CreERT2 transgenic mice were mated with either pMes-caBmprIa
or pMes-caBmprIb conditional transgenic mice, and timed pregnant
females were injected intraperitoneally once with tamoxifen (Sigma)
at embryonic day 12.5 (E12.5). Each mouse received a single injection
of 200-μl tamoxifen solution, dissolved in corn oil (Sigma), at the
ﬁnal concentration of 1 mg/20 g body weight. Tail sample of each
harvested embryo was subjected to PCR-based genotyping. Primer
information for PCR-based genotyping for these mouse lines is
available upon request. Use of animals in this study was approved
by the Institutional Animal Care and Use Committee (IACUC) of
Tulane University, and was in strict accordance with the recommen-
dations in the Guide for Care and Use of Laboratory Animals of the
National Institutes of Health.
Skeletal preparation, histology, immunostaining, in situ hybridization,
X-gal staining, and BrdU labeling assays
Skeletal staining was conducted by Alcian blue/Alizarin red staining
for cartilage and bone, as described previously (Zhang et al., 2000). For
histological analysis and section in situ hybridization assay, samples
were ﬁxed in 4% paraformaldehyde (PFA)/PBS at 4 1C for overnight,
dehydrated through graded ethanol, parafﬁn embedded, and sec-
tioned at 10 mm. Sections were subjected to standard Hematoxylin/
Eosin staining for histological examination, and to in situ hybridization
for gene expression assay using non-radioactive riboprobes, as
described previously (St. Amand et al., 2000). For immunohistochem-
ical staining, PFA ﬁxed samples were washed in 30% sucrose/PBS,
embedded in O.C.T. compound (Tissue-Tek) and cryo-sectioned at
10 mm. Prior to the application of primary antibody (anti-pSmad1/5/8;
from cell signaling), slides were treated with acetone for 10min and
air-dried. For immunostaining with antibodies against type II and type
X collagens, samples were processed the same as that for histological
analysis, and parafﬁn-embedded sections were subjected to immu-
nostaining, as described previously (Xiong et al., 2009). For X-gal
staining, samples were ﬁxed in 0.2% glutaraldehyde at 4 1C overnight,
washed in ice-cold PBS and subsequently with 30% sucrose/PBS,
embedded in O.C.T., and cryo-sectioned at 10 mm. X-gal staining was
conducted as described previously (Ito et al., 2003). All experiments
were repeated at least three times. To determine cell proliferation rate,
we performed Bromodeoxyuridine (BrdU) labeling experiment using
BrdU labeling and detection Kit (Roche Diagnostics Corp.), as described
previously (Xiong et al., 2009). BrdU-positive cells and total cell
number in a section of Meckel′s cartilage were counted on higher
magniﬁcation image on computer. Data collected from nine sections of
three samples (three continuous sections from each sample) of either
control or mutant were subjected to statistical analysis. The outcome
was presented as percentage of labeled cells among total cells in
Meckel′s cartilage, and Student′s t-test was used to determine the
signiﬁcance of difference.Results
Expression of Noggin and Bmp genes in developing Meckel′s cartilage
To investigate the role of Noggin and BMP signaling in Meckel′s
cartilage development and degeneration, we examined the expression
of Noggin and several Bmp genes including Bmp2, Bmp4, and Bmp7 in
the middle portion of Meckel′s cartilage. We used the ﬁrst molar germ
as a landmark for our analyses, since the development of Meckel′s
cartilage initiates at this region. We took advantage of Nog+/ mice in
which the Noggin coding sequences were replaced with the LacZ
reporter gene by targeted knock-in approach (McMahon et al., 1998).
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time Meckel′s cartilage condensation appears to the last day day of
gestation (E18.5). As shown in Fig. 1, LacZ activity was detected,
though relatively weaker, in forming Meckel′s cartilage at E11.5
(Fig. 1A). Strong X-gal staining was observed in Meckel′s cartilage at
E12.5 (Fig. 1B), and remained there throughout the entire embryonic
stage (Figs. 1C and D). In situ hybridization assay conformed Noggin
expression in Meckel′s cartilage (inset in Fig. 1C). We performed in situ
hybridization assay to examine Bmp gene expression. Since all these
three Bmp genes are expressed in the developing tooth, their expres-
sion in tooth germ was therefore used as positive control for in situ
hybridization assay. We found that Bmp2 is expressed in Meckel′s
cartilage condensation at E11.5, and the expression becomes stronger
at E12.5 (Figs. 2A and D). However, from E13.5 on, Bmp2 expression
became undetectable inMeckel′s cartilage, though lower level of Bmp2
expression was observed in surrounding mandibular mesenchyme
and mandibular bone (Fig. 2G, J and M). While Bmp4 expression was
never observed in developing Meckel′s cartilage in all stages exam-
ined, we did detect Bmp4 transcripts in the surrounding mandibular
mesenchyme and mandibular bone at E11.5 to E13.5 as well as E16.5
(Fig. 2B, E, H, K, and N). Bmp7 expression was found in Meckel′s
cartilage and surrounding mandibular mesenchyme at relatively lower
levels at E11.5 and E12.5 (Fig. 2C and F). However, at E13.5, Bmp7
expression disappeared, but was detected in the adjacent forming
mandibular bone (Fig. 2I). At the following E14.5 and E16.5 stages,
Bmp7 expression was not found in Meckel′s cartilage as well as
surrounding tissues (Fig. 2L and O). These results reveal dynamic
expression patterns of these Bmp genes and implicate potential role of
BMP signaling in Meckel′s cartilage development.
Lack of Noggin leads to enlargement and endochondral ossiﬁcation
of Meckel′s cartilage
In our and other′s previous studies, the presence of signiﬁcantly
thickened Meckel′s cartilage in Noggin-deﬁcient embryos was noticed
(He et al., 2010; Lana-Elola et al., 2011; Wang et al., 2011). Indeed,Fig. 1. Expression of Noggin in developing Meckel′s cartilage. Noggin expression, as asse
cartilage at E11.5 (A), and in Meckel′s cartilage through subsequent stages of embryogen
Meckel′s cartilage M, Meckel′s cartilage. Scale bar¼100 mm.skeleton preparations of embryonic heads revealed enlarged cranio-
facial cartilages in the mutants at E14.5 including Meckle′s cartilage,
nasal cartilage, basisphenoid, and presphenoid, as compared to the
controls (Fig. 3A and B). At E18.5, similar to the control, the enlarged
causal end and symphysis of Meckel′s cartilage in the mutants
remained an unossiﬁed status (Fig. 3C–F). To determine the develop-
mental process and fate of the middle portion of Meckel′s cartilage in
Nogginmutants, we made detailed histological analysis. We found that
mesenchymal condensations of Meckel′s cartilage in Nog / embryos
formed at the same time as that in the control at E11.5, evidenced by
the expression of Sox9 (Fig. 4A and B). Comparing to the controls, the
Sox9 expression domain in the mutants appeared larger at this
stage, suggesting recruitment of more cells to the blastema of
mutant Meckel′s cartilage. At E12.5, Meckel′s cartilage in both
controls and mutants became discernibly larger in diameter
(Fig. 4C and D). At E14.5, the size of Meckel′s cartilage increased
only slightly in wild type controls (Fig. 4E), but became signiﬁcantly
larger in mutants (Fig. 4F). At E16.5 when chondrocytes had become
hypertrophic and degeneration began in control Meckel′s cartilage
(Harada and Ishizeki, 1998; Sakakura et al., 2005), the mutant
counterpart had undergone extensive endochondral ossiﬁcation at
the ﬁrst molar level (Fig. 4G and H). However, at the posterior
region of the middle portion, endochondral ossiﬁcation had not yet
begun at this stage (Fig. 4J). At E18.5 when degeneration of Meckel′s
cartilage appeared obviously in controls (Fig. 4K), Meckel′s cartilage
in Nog / mutants had almost ossiﬁed and integrated into man-
dibular bone (Fig. 4L). At this time, the posterior middle portion had
also begun to ossify (Fig. 4N), indicating delayed chondrogenic
differentiation and endochondral ossiﬁcation in the posterior
domain. These observations demonstrate that in the absence of
Noggin, Meckel′s cartilage becomes dramatically enlarged, and the
middle portion of Meckel′s cartilage continues the chondrogenic
differentiation process and eventually undergoes endochondral
ossiﬁcation instead of degeneration.
To further conﬁrm that Meckel′s cartilage in Nog / mice under-
goes the similar chondrogenic differentiation process as that inssed by LacZ activity, is seen in the initial mesenchymal condensation of Meckel′s
esis (B–D). Inset in (C) shows in situ hybridization detection of Noggin expression in
Fig. 2. Expression of Bmp2, Bmp4, and Bmp7 in developing Meckel′s cartilage. (A–C) In situ hybridization shows Bmp2 and Bmp7 but not Bmp4 expression in mesenchymal
condensation of Meckel′s cartilage at E11.5. Note: Bmp2 expression in the dental epithelium (arrow in panel A) and Bmp4 expression in the dental mesenchyme (arrow in
panel B). (D–F) At E12.5, strong Bmp2 expression and relatively weaker Bmp7 expression but not Bmp4 is detected in Meckel′s cartilage. In addition, all three Bmp genes are
expressed in the surrounding mesenchymal tissues. (G–O) At E13.5 and subsequently developmental stages at E14.5 and E16.5, these Bmp genes are no longer expressed in
Meckels′ cartilage but are expressed at lower levels in the surrounding mesenchymal tissues and developing mandibular bone. M, Meckel′s cartilage; T, tooth; Mb,
mandibular bone; Sek, secondary enamel knot. Scale bar¼100 mm.
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differentiation markers at the ﬁrst molar level: collagen type II
(Col II), a marker for chondrocytes, Ihh, a marker for prehypertrophic
chondrocytes, and collagen type X (Col X), a marker for hypertrophic
chondrocytes. Our results showed that at E14.5, Col II expression was
detected in Meckel′s cartilage in controls and Nog / mice (Fig. 5A
and B). However, at this stage, expression of Ihh and Col X was alsodetected in Nog / mutants but was not in the controls (Fig. 5F
and J), indicating that Meckel′s cartilage in the mutant had under-
gone chondrogenic differentiation. At E16.5, Col II expression
became barely detectable in the controls (Fig. 5C), but was present
in a few undifferentiated chondrocytes in the mutant (Fig. 5D). At
this stage, Ihh and Col X expressions were also absent in the control
(Fig. 5G and K), despite the presence of hypertrophic chondrocytes
Fig. 3. Enlarged craniofacial cartilages in Noggin mutants. (A, B) Skeleton preparations of control (A) and Nog / (B) heads at E14.5 reveal generally enlarged craniofacial
cartilages in the Noggin mutants. (C, D) Skeletal staining of mandibular arches of E18.5 control (C) and mutant (D) shows enlarged but unossiﬁed caudal end (arrows) of
Meckel′s cartilage in mutant. (E, F) Coronal sections of E18.5 control (E) and Nog/ mutant (F) reveal enlarged and unossiﬁed symphysis in the mutant. I, incisor; S,
symphysis; BS, basisphenoid; MC, Meckel′s cartilage; NC, nasal cartilage; PS, presphenoid; Dnt, dentary. Scale bar¼2 mm (A–D); 500 mm (E, F).
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of lack of Col X expression in hypertrophic chondrocytes in the
middle portion of Meckel′s cartilage is consistent with the previous
report (Chung et al., 1995), suggesting that the cellular hypertrophy
of Meckel′s cartilage is not necessarily associated with the expres-
sion of chondrogenic differentiation markers. In the mutant at this
stage, while Ihh expression was no longer detectable, Col X was
found in remaining chondrocytes that underwent ﬁnal differentia-
tion (Fig. 5Jand L), consistent with histological evidence that the
middle portion of Meckels′ cartilage in Nog/ mutants have
undergone extensive chondrogenic differentiation and endochon-
dral ossiﬁcation at this stage. To examine if there is an invasion of
adjacent Noggin-negative mandibular mesenchymal cells into
mutant Meckel′s cartilage that may function to resorb Meckel′s
cartilage during its chondrogenic differentiation, we made LacZ
staining on E14.5 mutant Meckel′s cartilage that had undergone
chondrogenic differentiation. As shown in the inset in Fig. 5J, allcells in mutant Meckel′s cartilage are LacZ positive, suggesting a
lack of invasion of cells from adjacent tissues.
Absence of Noggin leads to upregulated BMP signaling and elevated
cell proliferation in Meckel′s cartilage
To determine if the absence of Noggin alters BMP signaling
activity, we performed immunohistochemical staining to examine
the expression of phosphorylated Smad1/5/8 (pSmad1/5/8). In
wild type controls, at E12.5 when Bmp2 is strongly expressed in
Meckel′s cartilage (Fig. 2), relatively abundant pSmad1/5/8 posi-
tive cells were detected (Fig. 6A). However, at E13.5 when Bmp
genes are no longer expressed in Meckel′s cartilage (Fig. 2), the
number of pSmad1/5/8 positive cells accordingly decreased dra-
matically (Fig. 6C). In contrast, as we expected, the number of
pSmad1/5/8 positive cells increased signiﬁcantly in Nog /
Meckel′s cartilage compared to the controls at both stages
Fig. 4. Lack of Noggin leads to formation of enlarged Meckel′s cartilage and
endochondral ossiﬁcation. (A, B) In situ hybridization shows Sox9 expression in
mesenchymal condensations of Meckel′s cartilage in control and Nog/ embryos at
E11.5. (C–F) Histological sections through the middle portion of Meckel′s cartilage of
E12.5 and E14.5 control and Nog/ embryos show enlarged Meckel′s cartilage in
mutants. (G, H) Histological sections through the ﬁrst molar level of mandible show
Meckel′s cartilage with hypertrophic chondrocytes in E16.5 control mice (G) and
Meckel′s cartilage in E16.5 Nog/ mice that are undergoing endochondral ossiﬁca-
tion (H). (I, J) histological sections through the posterior part of middle portion of
E16.5 control (I) and Nog/ mutant (J) show enlarged Meckel′s
cartilage in the mutant that has not yet started endochondral ossiﬁcation process.
(K–N) Coronal sections through the ﬁrst molar region (K, L) and the posterior region
(M, N) of the middle portion of Meckel′s cartilage of E18.5 control (K, M) and mutant
(L, N) show degenerating Meckel′s cartilage in controls and almost completely
ossiﬁed Meckel′s cartilage at the ﬁrst molar level and Meckel′s cartilage undergoing
endochondral ossiﬁcation in the posterior region in mutants. M, Meckel′s cartilage; T,
tooth; Scale bar¼100 mm.
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a level of pSmad1/5/8 positive cells similar to that at E13.5, the
amount of pSmad1/5/8 positive cells began to reduce
(Fig. 6E and F).Fig. 5. Expression of chondrogenic differentiation markers in developing Meckel′s
cartilage of Nog/ mutants. (A–D) Expression of Col II is seen in Meckel′s cartilage
of wild type control and Nog/ embryos at E14.5 (A, B), but is barely detectable in
wild type Meckel′s cartilage at E16.5 (C). Col II expression is also observed in some
undifferentiated chondrocytes (arrowheads) of Nog / Meckel′s cartilage at E16.5
(D). (E–H) The prehypertrophic chondrocyte marker Ihh is never expressed in
control Meckel′s cartilage at E14.5 (E) and E16.5 (G). In contrast, Ihh is strongly
expressed in Nog/ Meckel′s cartilage at E14.5 (F) but not at E16.5 (H). (I–L) Col X
expression is not detected in the middle portion of Meckel′s cartilage in wild type
embryos at E14.5 (I) and E16.5 (K), but is seen in Nog/ Meckel′s cartilage at both
stages (J, L). Inset in (J) shows that all cells in E14.5 Nog/ Meckel′s cartilage are
LacZ-positive. M, Meckel′s cartilage; T, tooth. Scale bar¼100 mm.
Fig. 6. Elevated pSmad activity in Nog/ Meckel′s cartilage. (A–F) Immunohistochemical staining show pSmad1/5/8 positive cells in control and Nog/ Meckel′s cartilage.
At E12.5, control Meckel′s cartilage has relatively high number of pSmad1/5/8 positive cells (A), but at E13.5 and E14.5, it contains only a few positive cells (C, E). In contrast,
the number of pSmad1/5/8 positive cells increases signiﬁcantly in Nog / Meckel′s cartilage at E12.5 (B) and E13.5 (D). However, at E14.5, the number of pSmad1/5/8
positive cells is reduced in Nog / Meckel′s cartilage (F). Scale bar¼100 mm.
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enlarged Meckel′s cartilage is a consequence of increased cell prolife-
ration rate. We found that cell proliferation rate was indeed increased
signiﬁcantly (Po0.001) in mutants as compared with that in controls
at E12.5 (Fig. 7A, B, and G). However, at E14.5, we did not detect a
signiﬁcant difference in cell proliferation rates between controls and
mutants (Fig. 7C, D, and G), consistent with the reduced amount of
pSmad1/5/8 positive cells in mutant Meckel′s cartilage. This observa-
tion could be attributed to the fact that the chondrocytes in mutant
Meckel′s cartilage had begun to differentiate at this stage, as assessed
by the expression of chondrogenic differentiation markers shown
above. Elevated cell proliferation rate was also found in other cranial
cartilages such as presphenoid (Fig. 7E, F, and H), suggesting that
elevated cell proliferation represents at least one of the mechanisms
underlying the enlargement of cranial cartilages in Noggin mutants.
Activation of BMPRIa-mediated signaling in Meckel′s cartilage
resembles effect of Noggin-deﬁciency
Because Bmp2 and Bmp7 are expressed in developing Meckel′s
cartilage only at early stages (E11.5 and E12.5), but are no longerexpressed there from E13.5 on, despite continuous expression of these
two Bmps as well as Bmp4 in the surrounding mesenchyme and
developing mandibular bones at late stages, we wondered if the
withdrawal of BMP signaling in developing Meckel′s cartilage repre-
sents a critical step for the arrest of further chondrogenic differentia-
tion and subsequent degeneration. To address this question, we
generated conditional transgenic mice that expressed a constitutively
active form of either BMPRIa (caBmprIa) or BMPRIb (caBmprIb) in
chondrocyte lineage. The inducible transgenic allele Col2a1-CreERT2,
upon administration of tamoxifen, gives rise to high speciﬁcity and
strong efﬁciency of Cre recombination activity in chondrocytes includ-
ing Meckel′s cartilage (Chen et al., 2007; Fig. 8A). We found that the
expression of caBmprIb, activated by administration of tamoxifen at
E12.5, did not produce a phenotype in Meckel′s cartilage (Fig. 8B;
N¼5), despite previous evidence for the functional efﬁciency of this
transgenic allele in rescuing tooth defects in mice lacking BmprIa and
in causing severe ichthyosis-like skin phenotype in mice expressing
this transgenic allele in the skin (Yu et al., 2010; Li et al., 2011).
However, when caBmprIa was activated in chondrocytes after tamox-
ifen administration, enlarged Meckel′s cartilage was found in Col2a1-
CreERT2; pMes-caBmprIa mice (Fig. 8Cand D; N¼5). The enlarged
Fig. 7. Lack of Noggin leads to elevated cell proliferation rate in Meckel′s cartilage. (A–D) Coronal sections show BrdU labeled cells in control and Nog/ Meckel′s cartilage
at E12.5 and E14.5. (E, F) Coronal sections show BrdU labeled cells in presphehoid of E14.5 control (E) and mutant (F). (G) Statistical analysis shows signiﬁcantly increased cell
proliferation rate in Nog/ Meckel′s cartilage at E12.5 (Po0.001) but not at E14.5 (P40.2) as compared to controls. (H) Statistical analysis shows signiﬁcantly increased cell
proliferation rate (Po0.05) in the presphenoid in E14.5 Nog/ embryo as compared to that in control. Standard errors are indicated. Scale bar¼100 mm.
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assessed by the expression of Ihh and Col X, mimicking the phenotype
observed in Nog / mice (Fig. 8E and F; N¼2).Discussion
As a transient embryonic structure, Meckel′s cartilage disappears
through different ultimate fates of the chondrocytes depending on
their position (Bhaskar et al., 1953; Frommer and Margolies, 1971;
Richman and Diewert, 1988; Harada and Ishizeki, 1998). It has beenwell established that the majority of Meckel′s cartilage, the middle
portion, undergoes degeneration. Despite that the chondrocytes in this
portion become hypertrophic, they do not express chondrogenic
differentiation markers, such as Col X and Ihh (Chung et al., 1995; this
study), suggesting an arrest of chondrogenic differentiation prior to
degeneration. Previous studies have implicated multiple factors and
cellular processes in degeneration and resorption of Meckel′s cartilage,
including several matrix metalloproteinases (Ishizeki and Nawa,
2000; Sakakura et al., 2007a, 2007b), macrophages ( Harada and
Ishizeki, 1998; Sakakura et al., 2005; Tsuzurahara et al., 2011), and
possible autophagy and apoptosis (Trichilis and Wroblewski, 1997;
Fig. 8. Activation of BMPRIa-mediated BMP signaling in chondrocyte-lineage resembles Nog/ Meckel′s cartilage phenotype. (A) X-gal staining shows Cre activity in
chondrocytes of Meckel′s cartilage of an E14.0 Col2a1-CreERT2;R26R embryo that received an administration of tamoxifen at E12.5. (B) A coronal section of an E16.5 Col2a1-
CreERT2; pMes-caBmprIb embryo shows unaffected Meckel′s cartilage. (C, D) Coronal sections E15.5 Col2a1-CreERT2; pMes-caBmprIa embryos show signiﬁcantly enlarged
Meckel′s cartilage. (E, F) In situ hybridization assay shows Ihh expression (E) and Col X expression (F) in enlarged Meckel′s cartilage of E15.5 Col2a1-CreERT2; pMes-caBmprIa
embryo. M, Meckel′s cartilage; T, tooth. Scale bar¼100 mm.
Y. Wang et al. / Developmental Biology 381 (2013) 301–311 309Yang et al., 2012). However, the underlying mechanism that is
responsible for the arrest of chondrogenic differentiation and subse-
quent degeneration of Meckel′s cartilage remains unknown.
In this study, we investigated the role of BMP signaling in Meckel′s
cartilage development using Nog/ mice as a gain-of BMP function
model. We focused our studies on the middle portion of Meckel′s
cartilage because of its distinct ultimate fate. We found that in the
absence of Noggin, which leads to elevated BMP signaling and cell
proliferation rate, the fate of chondrocytes in this portion is changed.
Meckel′s cartilage becomes enlarged and undergoes further chondro-
genic differentiation and endochondral ossiﬁcation. This phenotype is
resembled by expression of a constitutively active form of BmprIa in
chondrocyte lineage, indicating that suppression of BMP activity is
essential for normal Meckel′s cartilage development and the ultimate
fate of the chondrocytes. Interestingly, the caudal end and the
symphysis of Meckel′s cartilage, both undergo endochondral differ-
entiation eventually in wild type animals, also became enlarged in
Noggin mutants. However, they exhibited similar chondrogenic differ-
entiation status in the mutants at the end of gestation as compared tothe controls, suggesting that loss of Noggin may not alter the fate of
chondrocytes in these two compartments.
BMP signaling has been shown to play critical roles in multiple
steps of chondrogenesis and endochondral ossiﬁcation. In developing
Meckel′s cartilage, Bmp2 and Bmp7 are expressed in the mesenchymal
condensation and chondrocytes of Meckel′s cartilage at early stage,
consistent with the role of BMP signaling in promoting differentiation
of mesenchymal cells into chondrocytes and stimulating chondrocyte
proliferation (Denker et al., 1999; Zehentner et al., 1999; Yoon et al.,
2005). However, the expression of these two genes is abruptly
inhibited in Meckel′s cartilage at E13.5, and never comes back. In
accord with this inhibition of Bmp gene expression is the dramatically
reduced BMP signaling activity in Meckel′s cartilage after this stage.
The residual BMP signaling activity present in Meckel′s cartilage from
E13.5 on could be the consequence of the expression of Bmp2, Bmp4,
and Bmp7 in the surrounding mesenchyme and the developing
mandibular bone. Since BMP signaling also induces/stimulates chon-
drocyte hypertrophy and is required for endochondral bone formation
(Valcourt et al., 2002; Kobayashi et al., 2005; Retting et al., 2009), the
Y. Wang et al. / Developmental Biology 381 (2013) 301–311310suppression of Bmp expression appears to responsible for the arrest of
chondrogenic differentiation and subsequent endochondral ossiﬁca-
tion. Interestingly, although cellular hypertrophy is seen in the
chondrocytes of Meckel′s cartilage, these hypertrophic chondrocytes
never express chondrogenic differentiation markers including Ihh and
Col X, suggesting an abnormal hypertrophic process. It was shown
previously that Col X expression is closely associated with the
hypertrophic chondrocyte differentiation that undergoes endochon-
dral ossiﬁcation (Solursh et al., 1986). Thus the absence of Col X
expression in Meckel′s cartilage could be responsible, at least partially,
for the lack of endochondral ossiﬁcation.
BMP signaling is known to be transduced by a type II receptor
together with two originally identiﬁed type I receptors (BMPRIa
and BMPRIb) as well as activin receptor type IA (ActRIa). These
type I BMP receptors appear to have distinct but overlapping
function during embryogenesis. In the developing chick limb,
expression of caBmprIa but not caBmprIb promotes chondrogenic
differentiation (Zou et al., 1997). Similarly in mice, expression of
caBmprIa in chondrocytes accelerates chondrogenic differentiation
in the axial and appendage skeletal elements (Kobayashi et al.,
2005). Consistent with these previous ﬁndings, in our current
study, we show that expression of caBmprIa but not caBmprIb in
chondrocyte lineage induces formation of signiﬁcantly enlarged
Meckel′s cartilage and enhances chondrogenic differentiation,
indicating that BMPRIa and BMPRIb have distinct function in
regulating chondrogenesis of CNC-derived cells in mice. Interest-
ing, tissue-speciﬁc inactivation of BmprIa in the CNC lineage did
not affect the size of Meckel′s cartilage (Li et al., 2011), suggesting
potential functional redundancy between BmprIa and other type I
BMP receptors such as BmprIb whose knockout did not give rise to
any obvious craniofacial defect (Baur et al., 2000; Yi et al., 2000).
On the other hand, in the developing chicken face, mis-expression
of either caBmprIa or caBmprIb similarly produced enlarged cranial
cartilages including Meckel′s cartilage (Ashique et al., 2002),
suggesting a species speciﬁc function of BMPRIB-mediated signal-
ing in the regulation of chondrogenesis during craniofacial devel-
opment. Nevertheless, these observations support the idea that
despite different origins of germ layer and different species,
BMPRIa-mediated signaling has a conserved role in promoting
chondrogenesis.
In conclusion, in this study, we provide evidence that precisely
regulated Bmp gene expression and BMP signaling activity is
essential for normal development of the middle portion of
Meckel′s cartilage and its ultimate chondrocyte fate. Withdrawal
of BMP signaling leads to arrest of chondrogenic differentiation
and subsequent degeneration of this portion of Meckel′s cartilage
during embryogenesis. Elevation of BMP signaling activity in the
absence of Noggin or maintenance of BMP signaling activity by
expression of caBmprIa enhances chondrogenic differentiation,
leading to endochondral ossiﬁcation of the middle portion of
Meckel′s cartilage.Acknowledgments
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